Literature DB >> 19428907

Further analysis of protection induced by the MIC3 DNA vaccine against T. gondii: CD4 and CD8 T cells are the major effectors of the MIC3 DNA vaccine-induced protection, both Lectin-like and EGF-like domains of MIC3 conferred protection.

Alaa Bassuny Ismael1, Dorsaf Hedhli, Odile Cérède, Maryse Lebrun, Isabelle Dimier-Poisson, Marie-Noëlle Mévélec.   

Abstract

The present study was conducted mainly to evaluate the contribution of the cellular and the humoral responses in protection conferred by the MIC3 DNA vaccine (pMIC3i) that was proved as a potent vaccine against toxoplasmosis. We performed the adoptive transfer of CD4(+) and CD8(+) T lymphocytes from pMIC3i immunized mice to naive ones and the role of humoral immunity was evaluated by in vitro invasion assays. We also constructed plasmids encoding the EGF-like domains and the Lectin-like domain of MIC3, to define which domains of MIC3 are involved in the protection. Furthermore, the adjuvant effect of the GM-CSF-expressing vector (granulocyte-macrophage colony-stimulating factor) required the precise temporal and spatial codelivery of GM-CSF with antigen, thus, we constructed a bicistronic plasmid expressing MIC3 and GM-CSF. In conclusion, the protection induced by pMIC3i was mainly mediated by CD4(+) and CD8(+) T lymphocytes and both EGF and Lectin domains of MIC3 conferred protection. Furthermore, the codelivery of GM-CSF by a bicistronic plasmid appeared to be a most effective way for enhancing the adjuvant properties of GM-CSF.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19428907     DOI: 10.1016/j.vaccine.2009.02.107

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  6 in total

1.  Enhancement of the protective efficacy of a ROP18 vaccine against chronic toxoplasmosis by nasal route.

Authors:  Imran Rashid; Nathalie Moiré; Bruno Héraut; Isabelle Dimier-Poisson; Marie-Noëlle Mévélec
Journal:  Med Microbiol Immunol       Date:  2016-10-18       Impact factor: 3.402

Review 2.  REVIEW OF DNA VACCINE APPROACHES AGAINST THE PARASITE TOXOPLASMA GONDII.

Authors:  Rosalie C Warner; Ryan C Chapman; Brianna N Davis; Paul H Davis
Journal:  J Parasitol       Date:  2021-11-01       Impact factor: 1.276

Review 3.  Research advances in microneme protein 3 of Toxoplasma gondii.

Authors:  Yanhua Wang; Hong Yin
Journal:  Parasit Vectors       Date:  2015-07-22       Impact factor: 3.876

Review 4.  Recent progress in microneme-based vaccines development against Toxoplasma gondii.

Authors:  Masoud Foroutan; Leila Zaki; Fatemeh Ghaffarifar
Journal:  Clin Exp Vaccine Res       Date:  2018-07-31

5.  Assessment of DNA vaccine encoding Toxoplasma gondii microneme complete gene and IL-12 as adjuvant in BALB/c mice.

Authors:  Fatemeh Ghaffarifar; Mohammad Jafarimodrek; Hossein Vazini; Zohreh Sharifi; Abdolhossein Dalimi; Mohammad Saaid Dayer
Journal:  Iran J Basic Med Sci       Date:  2019-08       Impact factor: 2.699

6.  Identification and Characterization of Eimeria tenella Microneme Protein (EtMIC8).

Authors:  Ningning Zhao; Shuzhen Ming; Lingyu Sun; Bingxiang Wang; Hongmei Li; Xiao Zhang; Xiaomin Zhao
Journal:  Microbiol Spectr       Date:  2021-08-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.